GEMAROMA Gem Aromatics Q1 FY27 results (Apr–Jun 2026) and concall
Gem Aromatics Limited reported a 12.5% YoY consolidated revenue growth to ₹99 crores in Q1 FY27, but posted a consolidated loss of ₹7.9 crores. This was primarily due to higher depreciation from the capitalized Dahej facility and increased operating costs, coupled with raw material supply disruptions in the clove business. The company is focused on commercializing new high-margin products from its Dahej plant, with meaningful revenue contributions expected from Q3 FY27 and FY28.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 12.8%, net profit down 198.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 97 | 202 | 88 | 90 −20% | 79 −19% | 110 −45% | 99 +13% |
| EBITDA | 15 | 13 | 46 | 15 | 3 −80% | 7 −46% | 16 −66% | 3 −78% |
| Net profit | 10 | 7 | 28 | 8 | -3 −126% | -5 −167% | 1 −96% | -8 −199% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
